Home
 > Research and Reports > White Papers > Why Life Sciences Companies Should Engage on Social M...

Why Life Sciences Companies Should Engage on Social Media

Source: Wipro Technologies
While most industries are rapidly adopting social media to engage with customers, the life sciences companies remain typically balk at extending social presence in a highly regulated environment. In view of recent Food and Drug Administration (FDA) guidelines on the responsibilities of life sciences companies monitoring social media, this paper intends to assist life sciences companies in determining the scope and potential impact of creating a social media engagement program.


Featured publications:

How Analytics Bring Organizations Closer to Their Customers
Source: King Fish Media Social media is providing organizations with a plethora of data about their customers. This paper explains how to leverage business intelligence software and advanced analytics to change the way business is conducted. The end goal should be to personalize marketing messages in a way that allows organizations to narrowly target specific customers based on the knowledge of the customer they already have. Read More...
Social Media Analytics: Making Customer Insights Actionable
Source: IBM Social media is reshaping the relationships that customers have with products, services, and brands. Read this white paper from IBM to learn how you can use insights from social media to understand emerging consumer trends and increase the ROI of your marketing campaigns. Read More...
Customer Analytics in the Age of Social Media
Source: TDWI Read this Best Practices Report from The Data Warehousing Institute (TDWI) on capturing and analyzing social media networking activity - the new frontier for customer intelligence. Read More...


You may also be interested in these related documents:

The State of Global Clinical Research Trials
Source: UBM Tech New technologies and changing economic conditions have triggered a number of changes in the pharmaceuticals, life sciences, and biotech sectors. Increased global sales of life sciences products and growing demand for drugs present drug industry companies with a host of opportunities. However, the mandate for clinical trials has led to considerable inflation in their research and development (R&D) expenditure. The resolution lies in using emerging markets as an alternative to conduct these trials. Thanks to new technologies, the cloud, and social media/online portals, the pharmaceuticals, life sciences and biotech sectors can make the most of the emerging opportunities. Learn how. Read More...
Social Media and Customer Experience Feedback
Source: Mindshare Technologies Twitter, Facebook, LinkedIn, and blogs are just a few Internet services that make up the new growing digital world called social media. Many companies have seen the influence these new sites can have on their organizations for both good and bad. All companies should ask themselves, "How can we tap into the power of this new method of communication to improve our business and the experiences we provide our customers?" Read More...
ERP Issues for the Midsized Life Sciences Company
Source: Microsoft What makes your enterprise resource planning (ERP) requirements difficult for most vendors to satisfy? As a life sciences company, you have operational processes that set you apart from other manufacturing companies. And, your regulatory requirements, including 21 CFR part 11, aren’t like those of any other industry. The challenge is to manage compliance risks and compliance costs. Learn about an ERP compliance strategy. Read More...

 
comments powered by Disqus



Recent Searches
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Others

©2014 Technology Evaluation Centers Inc. All rights reserved.